1. Home
  2. DTSS vs ADVB Comparison

DTSS vs ADVB Comparison

Compare DTSS & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

BUY

Current Price

$0.55

Market Cap

7.4M

Sector

Technology

ML Signal

BUY

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$4.80

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTSS
ADVB
Founded
2014
2014
Country
China
Hong Kong
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.6M
IPO Year
2026
2023

Fundamental Metrics

Financial Performance
Metric
DTSS
ADVB
Price
$0.55
$4.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 281.2K
13.4K
Earning Date
10-05-2026
10-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3431.25
EPS
N/A
★ 5.33
Revenue
N/A
★ $127,637.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$0.75
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$3.66
52 Week High
$2.29
$113.80

Technical Indicators

Market Signals
Indicator
DTSS
ADVB
Relative Strength Index (RSI) 35.00 37.08
Support Level N/A $3.86
Resistance Level $0.98 $5.59
Average True Range (ATR) 0.07 0.53
MACD -0.02 -0.10
Stochastic Oscillator 3.70 36.67

Price Performance

Historical Comparison
DTSS
ADVB

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: